1. YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine
   Zhengdong Jiang et al, 2016, Nutrients CrossRef
2. Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway
   Yan Zhang et al, 2016 CrossRef
3. A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer
   Macarena Perán et al, 2017, Sci Rep CrossRef
4. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer
   Steven M. Mooney et al, 2017, J. Cell. Biochem. CrossRef
5. Disruption of adherens junction and alterations in YAP-related proliferation behavior as part of the underlying cell transformation process of alcohol-induced oral carcinogenesis
   Ayman Husari et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
6. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma
   Yijun Zhang et al, 2017, J. Cell. Mol. Med. CrossRef
7. Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas
   Don L. Gibbons et al, 2018, Dev. Dyn. CrossRef
8. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma
   Massimiliano Cadamuro et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
9. Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
   Oleg Dobrokhotov et al, 2018, Clin Trans Med CrossRef
10. The MST4–MOB4 complex disrupts the MST1–MOB1 complex in the Hippo–YAP pathway and plays a pro-oncogenic role in pancreatic cancer
    Min Chen et al, 2018, J. Biol. Chem. CrossRef
11. Chemoresistance and the Self-Maintaining Tumor Microenvironment
    Gulcen Yeldag et al, 2018, Cancers CrossRef
12. DYSREGULATION OF THE HIPPO PATHWAY SIGNALING IN AGING AND CANCER
    Yiu To Yeung et al, 2019, Pharmacological Research CrossRef
13. CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
    Andrew Sulaiman et al, 2019, Cancers CrossRef
14. Epithelial-to-Mesenchymal Transition in Paclitaxel-Resistant Ovarian Cancer Cells Is Downregulated by Luteolin
    Vermont P Dia et al, 2017, J. Cell. Physiol. CrossRef
15. The roles of the Hippo pathway in cancer metastasis
    Helena J. Janse van Rensburg et al, 2016, Cellular Signalling CrossRef
16. YAP/TAZ Related BioMechano Signal Transduction and Cancer Metastasis
    Bridget Martinez et al, 2019, Front. Cell Dev. Biol. CrossRef
17. YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine
    Ling Zhou et al, 2019, Biomolecules CrossRef
18. PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells
    Ashley L. Hein et al, 2019, Oncogenesis CrossRef
19. Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease
    James H. Monkman et al, 2019, Cancers CrossRef
20. Circulating lncRNA SNHG11 as a novel biomarker for early diagnosis and prognosis of colorectal cancer
    Wei Xu et al, 2019, Int. J. Cancer CrossRef
21. Insulin suppresses transcriptional activity of yes-associated protein in insulin target cells
    Samar Sayedyahossein et al, 2020, MBoC CrossRef
22. YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
    Barry J. Thompson, 2020, BioEssays CrossRef
23. Mechanisms of Hippo pathway in the pancreatic cancer
    Ruiling Xie et al, 2020, Journal of Pancreatology CrossRef
24. Nanostructured Architectures Promote the Mesenchymal-Epithelial Transition for Invasive Cells
    Zongjie Wang et al, 2020, ACS Nano CrossRef
25. Suppression of miR-16 promotes tumor growth and metastasis through reversely regulating YAP1 in human cholangiocarcinoma
    Sheng Han et al, 2017, Oncotarget CrossRef
26. MiR-195 suppresses the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
    Shuo Yu et al, 2017, Oncotarget CrossRef
27. Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal
    Tin Fan Chai et al, 2020, Oncogene CrossRef
28. miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2
    Li-Li Han et al, 2018, Int J Oncol CrossRef
29. Role of YAP in lung cancer resistance to cisplatin
    Juan Song et al, 2018, Oncol Lett CrossRef
30. Silence of Hippo Pathway Associates with Pro-Tumoral Immunosuppression: Potential Therapeutic Target of Glioblastomas
    Eui Hyun Kim et al, 2020, Cells CrossRef
31. Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment
    Edoardo D'Angelo et al, 2020, Front. Oncol. CrossRef
32. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2
    Guoan Wang et al, 2020, CBM CrossRef
33. Mechanically stressed cancer microenvironment: Role in pancreatic cancer progression
    Matthew Hadden et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
34. The potential role of YAP in head and neck squamous cell carcinoma
    Eunbie Shin et al, 2020, Exp Mol Med CrossRef
35. The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma
    Richard Drexler et al, 2020, J Cancer Res Clin Oncol CrossRef
36. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition
    Jaffer A Ajani et al, 2021, Gut CrossRef
37. The Hippo Signaling Pathway in Drug Resistance in Cancer
    Renya Zeng et al, 2021, Cancers CrossRef
38. Chinese Propolis Suppressed Pancreatic Cancer Panc-1 Cells Proliferation and Migration via Hippo-YAP Pathway
    Lingchen Tao et al, 2021, Molecules CrossRef
39. miR‑375/Yes‑associated protein axis regulates IL‑6 and TGF‑β expression, which is involved in the cisplatin‑induced resistance of liver cancer cells
    Kanru Yu et al, 2021, Oncol Rep CrossRef
40. Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
    Hiromitsu Hayashi et al, 2021, Front. Oncol. CrossRef
41. A dual role of YAP in driving TGFβ-mediated endothelial-to-mesenchymal transition
    Cecilia Savorani et al, 2021 CrossRef
42. Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells
    Margherita Grattarola et al, 2021, Free Radical Biology and Medicine CrossRef
43. YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).
    Jason W Lui et al, 2022, Pigment Cell Melanoma Res CrossRef
44. null
    Chih-Fan Yeh et al, 2021 CrossRef
45. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
    Kostas Palamaris et al, 2021, Cancers CrossRef
46. Hippo Pathway in Regulating Drug Resistance of Glioblastoma
    Giacomo Casati et al, 2021, IJMS CrossRef
47. Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target
    Sven Jonckheere et al, 2022, Cells Tissues Organs CrossRef
48. Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis
    Yu-Chan Chang et al, 2022, Cell Death Dis CrossRef
49. Relationship between Stemness, Reactive Oxygen Species, and Epithelial-to-Mesenchymal Transition in Model Circulating Tumor Cells
    Spenser R. Brown et al, 2022, Cells Tissues Organs CrossRef
50. Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers
    Yifei Wang et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
51. Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside
    Xiaoli Liu et al, 2022, Biomedicines CrossRef
52. Tissue fluidification promotes a cGAS–STING cytosolic DNA response in invasive breast cancer
    Emanuela Frittoli et al, 2022, Nat. Mater. CrossRef
53. Extracellular signal-Regulated Kinase 5 (ERK5) is required for the Yes-associated protein (YAP) co-transcriptional activity
    Francesca Ippolito et al, 2023, Cell Death Dis CrossRef
54. YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations.
    Richard Cunningham et al, 2023, Clin Transl Med CrossRef
55. On the Value of In Vitro Cell Systems for Mechanobiology from the Perspective of Yes-Associated Protein/Transcriptional Co-Activator with a PDZ-Binding Motif and Focal Adhesion Kinase and Their Involvement in Wound Healing, Cancer, Aging, and Senescence
    Thorsten Steinberg et al, 2023, IJMS CrossRef
56. Role of DCLK1/Hippo pathway in type II alveolar epithelial cells differentiation in acute respiratory distress syndrome
    Xiao-Yue Chen et al, 2023, Mol Med CrossRef
57. Dinaciclib exerts a tumor-suppressing effect via β-catenin/YAP axis in pancreatic ductal adenocarcinoma
    Yichen Li et al, 2024 CrossRef
58. Identification of a new class of activators of the Hippo pathway with antitumor activity in vitro and in vivo
    Guifeng Lin et al, 2024, Biochemical Pharmacology CrossRef
59. Identification and model construction of survival-associated proteins for pancreatic cancer based on deep learning
    Ying Chen et al, 2024, Future Generation Computer Systems CrossRef
60. Extracellular vesicles miR‐31‐5p promotes pancreatic cancer chemoresistance via regulating LATS2‐Hippo pathway and promoting SPARC secretion from pancreatic stellate cells
    Cheng Qin et al, 2024, J of Extracellular Vesicle CrossRef